Tscan Therapeutics Inc is trading at $0.90, up 5.9%, as the stock bounces back from a significant 10.8% decline in the previous session.
- The move appears to be a modest recovery or range trade following yesterday's drop to $0.85, which occurred without a clear company-specific catalyst.
- There have been no fresh news releases, SEC filings, or analyst updates as of June 17, 2026, to justify the move based on new fundamental information.
- The price action is characteristic of high volatility often seen in micro-cap biotech stocks during periods of low news flow.